GRI Bio, a biotechnology company based in La Jolla, California, has shared promising preclinical data on its potential treatment for Idiopathic Pulmonary Fibrosis (IPF)....
Investors are navigating the choppy waters of the stock market with caution as volatility continues to shake up portfolios. In times like these, it's...